Studies in solid tumors and hematological cancers have demonstrated a crucial role for the bromo and extraterminal (BET) domain protein BRD4 in promoting the cancer gene program especially in MYC-dependent tumors3–6. This evidence concerns the gene BRD4 and cancer.